Aigh Capital Management LLC Theratechnologies Inc. Transaction History

Aigh Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.78 - $1.01 $2,904 - $3,761	-3,724 Reduced 0.11%	3,404,710 $2.86 Million
Q1 2023 May 15, 2023	SELL	$0.72 - $1.12 $303,555 - $472,197	-421,605 Reduced 11.01%	3,408,434 $2.76 Million
Q4 2022 Feb 14, 2023	BUY	$0.83 - $2.3 $761,086 - $2.11 Million	916,972 Added 31.48%	3,830,039 $3.37 Million
Q2 2022 Aug 12, 2022	SELL	$2.21 - $2.7 $110,500 - $135,000	-50,000 Reduced 1.69%	2,913,067 $7.01 Million
Q1 2022 May 12, 2022	BUY	$2.37 - $3.24 $189,363 - $258,876	79,900 Added 2.77%	2,963,067 $7.34 Million

Q4 2021 Feb 10, 2022	SELL	$2.92 - $3.76 $408,417 - $525,907	-139,869 Reduced 4.63%	2,883,167 $8.72 Million
Q3 2021 Nov 12, 2021	SELL	$3.28 - $4.07 $1.81 Million - $2.25 Million	-552,697 Reduced 15.46%	3,023,036 $12 Million
Q1 2021 May 13, 2021	BUY	$2.2 - $3.94 $6.6 Million - $11.8 Million	2,998,919 Added 519.91%	3,575,733 $13.8 Million
Q4 2020 Feb 16, 2021	BUY	$1.91 - $2.5 $1.1 Million - $1.44 Million	576,814 New	576,814 $1.44 Million

29.2K

Ticker THTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,141,600
Market Cap $128M
Description
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aigh Capital Management LLC with notifications on news.